Skip to search formSkip to main contentSkip to account menu

hexarelin

Known as: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2, L-Lysinamide, L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Apomorphine SL (Uprima®): preclinical and clinical experiences learned from the first central nervous system-acting ED drug
An exclusive central site of action for the proerectile effect of apomorphine, including not only the brain but also the spinal… 
2002
2002
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection
Highly Cited
2000
Highly Cited
2000
Differential Orexigenic Effects of Hexarelin and Its Analogs in the Rat Hypothalamus: Indication for Multiple Growth Hormone Secretagogue Receptor Subtypes
We have previously reported that hexarelin and some of its analogs, including EP 50885, stimulated GH secretion and feeding after… 
1997
1997
Interaction of the growth hormone releasing peptide hexarelin with somatostatin
Growth hormone releasing peptides (GHRPs) are potent growth hormone (GH) secretagogues. Their interaction with growth hormone… 
1996
1996
Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children.
A clinical, prospective experiment was carried out to determine whether long-term intranasal administration of the growth hormone… 
Highly Cited
1995
Highly Cited
1995
Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
We have recently reported oral and parenteral bioactivity for a new GH-releasing peptide, hexarelin. In the present study, we… 
1995
1995
The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
Hexarelin (Hex) is a new synthetic hexapeptide with potent growth hormone (GH)-releasing activity in both animals and men. We… 
1995
1995
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty.
The objective of this study was to verify the GH-releasing activity of a synthetic hexapeptide, hexarelin (HEX), before and… 
Highly Cited
1994
Highly Cited
1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Although both spontaneous and stimulated GH secretion undergo an age-related decline, the secretory capacity of somatotrope cells… 
1994
1994
Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)
OBJECTIVE Hexarelin is a new synthetic growth hormone releasing peptide. We have tested the efficacy of intranasal (i.n… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)